Handbook of Psychopharmacology
Springer-Verlag New York Inc.
978-1-4684-3191-9 (ISBN)
1 Peptides and the Central Nervous System.- 1. Introduction.- 2. Hypothalamic Releasing Hormones: Animal Studies.- 3. Pituitary Peptide Hormones: Animal Studies.- 4. Other Brain Peptides: Animal Studies.- 5. Hypothalamic Releasing Hormones: Human Studies.- 6. Pituitary Peptide Hormones: Human Studies.- 7. Discussion.- 8. References.- 2 The Limbic-Hypothalamic-Pituitary-Adrenal System and Human Behavior.- 1. Introduction.- 2. Description of the Limbic-Hypothalamic-Pituitary-Adrenal System.- 3. Procedures for Evaluating LHPA Function in Humans.- 4. Relationship between Mental Phenomena and the LHPA System.- 5. Summary.- 6. References.- 3 Approaches to Brain Amines in Psychiatric Patients: A Reevaluation of Cerebrospinal Fluid Studies.- 1. Introduction.- 2. Methodological Considerations for Spinal Fluid Studies.- 3. CSF Amine Metabolites in Affective Illness.- 4. Amine Metabolism in Schizophrenic Patients.- 5. Pharmacological Approaches: Integration with Amine Metabolite Data.- 6. Theoretical Overview: The Question of Specificity.- 7. A Model for Defects in Compensatory and Regulatory Mechanisms.- 8. References.- 4 Amine Hypotheses of Affective Disorders.- 1. Introduction.- 2. Classification of Depressions.- 3. Serotonin Metabolism in Affective Disorders: Study of Peripheral Indicators.- 4. Metabolism of Catecholamines in Affective Disorders: Study of Peripheral Indicators.- 5. Postmortem Study of Central Monoamine Metabolism in Depressions.- 6. Central Monoamine Metabolism in Affective Disorders: CSF Studies Without Probenecid.- 7. Central Monoamine Metabolism in Affective Disorders: CSF Studies After Probenecid Loading.- 8. Verification of the Monoamine Hypothesis with the Aid of Drugs: I. Monoamine Precursors and Synthesis Inhibitors.- 9. Verification of the Monoamine Hypothesis with the Aid of Drugs and Other Methods of Antidepressant Therapy: II. Direct Influencing of the Transmission Process.- 10. Theories to Explain the Monoamine Deficiency in Depressions.- 11. Preliminaries to Expansion of the Monoamine Hypothesis 270 11.1 Acetylcholine.- 12. General Conclusions.- 13. References.- 5 Clinical Pharmacokinetics of Selected Psychotropic Drugs.- 1. Introduction.- 2. Tricyclic Antidepressants.- 3. Lithium.- 4. Benzodiazepines.- 5. CNS Stimulants (Amphetamine).- 6. Chlorpromazine.- 7. Conclusion.- 8. References.- 6 Behavioral Pharmacology of Antianxiety Drugs.- 1. Introduction.- 2. Anticonflict Properties of Antianxiety Agents.- 3. Properties of Antianxiety Agents in Miscellaneous Operant Conditioning Situations.- 4. Properties of Antianxiety Agents in Additional Behavioral Procedures.- 5. Concluding Remarks.- 6. References.- 7 Antianxiety Drugs: Clinical Use in Psychiatry.- 1. Introduction.- 2. Using Drugs to Treat Anxiety.- 3. Improving Specific Symptom Profiles of Anxious Patients.- 4. Predicting Improvement in Anxious Patients.- 5. Conclusion.- 6. References.
Zusatzinfo | XVI, 440 p. |
---|---|
Verlagsort | New York, NY |
Sprache | englisch |
Maße | 178 x 254 mm |
Themenwelt | Sachbuch/Ratgeber ► Natur / Technik ► Garten |
Geisteswissenschaften ► Psychologie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie | |
Medizin / Pharmazie ► Pharmazie | |
ISBN-10 | 1-4684-3191-9 / 1468431919 |
ISBN-13 | 978-1-4684-3191-9 / 9781468431919 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich